Добавил:
course-as.ru Авшаров Евгений Михайлович, ejen@course-as.ru Инвестор и Технический директор ООО 'КУРС-АС1', Москва, http://www.course-as.ru, Все наиболее важное обо мне:http://www.course-as.ru/Avsharov.html Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

PS-2020a / part17

.pdf
Скачиваний:
24
Добавлен:
01.06.2020
Размер:
39.56 Mб
Скачать

DICOM PS3.17 2020a - Explanatory Information​

Page 861​

Table JJJJ.5.2.1-8. CT Acquisition Details Macro Attributes​

Attribute Name​

Tag​

Values​

CT Acquisition Details Sequence​

(0018,9304)​

 

ITEM 1​

 

 

>Referenced Path Index​

(0018,9378)​

1\2​

>Rotation Direction​

(0018,1140)​

CW​

>Revolution Time​

(0018,9305)​

0.5​

>Single Collimation Width​

(0018,9306)​

0.625​

>Total Collimation Width​

(0018,9307)​

80.0​

>Table Height​

(0018,1130)​

88.5​

>Gantry/Detector Tilt​

(0018,1120)​

0​

>Data Collection Diameter​

(0018,0090)​

500​

Table JJJJ.5.2.1-9. CT Geometry Macro Attributes​

 

Attribute Name​

Tag​

Values​

CT Geometry Sequence​

(0018,9312)​

 

ITEM 1​

 

 

>Referenced Path Index​

(0018,9378)​

1\2​

>Distance Source to Detector​

(0018,1110)​

1140​

>Distance Source to Data Collection Center​

(0018,9335)​

570​

Table JJJJ.5.2.1-10. Multi-energy CT Processing Attributes​

Attribute Name​

Tag​

Values​

Decomposition Method​

(0018,937E)​

PROJECTION_BASED​

Decomposition Material Sequence​

(0018,9381)​

 

ITEM 1​

 

 

>Material Code Sequence​

(0018,937D)​

 

>>Include Table 8.8-1 “Code Sequence Macro Attributes” in PS3.3​

(11713004, SCT, "Water")​

ITEM 2​

 

 

>Material Code Sequence​

(0018,937D)​

 

>>Include Table 8.8-1 “Code Sequence Macro Attributes” in PS3.3​

(44588005, SCT, "Iodine")​

- Standard -​

Page 862​

DICOM PS3.17 2020a - Explanatory Information​

- Standard -​

DICOM PS3.17 2020a - Explanatory Information​

Page 863​

KKKK Encoding Quantitative Image Family​

Parameters (Informative)​

KKKK.1 Encoding of Quantitative Image Family Parameters With RWVM​

In this example, the real-world value mapped pixel value represents attenuation of water. The pixel values range from 0 to 4095 like​ a conventional CT Image and are mapped starting from -1024.​

Table KKKK.1-1. Example Material Specific Images for the Real World Value Mapping Macro​

Attribute​

Tag​

Value​

Comment​

Real World Value Mapping Sequence​

(0040,9096)​

 

 

ITEM 1​

 

 

 

>Real World Value First Value Mapped​

(0040,9216)​

0​

 

>Real World Value Last Value Mapped​

(0040,9211)​

4095​

 

>Real World Value Intercept​

(0040,9224)​

-1024​

 

>Real World Value Slope​

(0040,9225)​

1​

 

>LUT Explanation​

(0028,3003)​

"Water component of image​

 

 

 

with water and iodine as base​

 

 

materials"​

 

>LUT Label​

(0040,9210)​

MAT_SPECIFIC​

Per guidance in​

 

 

 

Section C.11.1.1.2.1​

 

 

 

“Recommended Rescale​

 

 

 

Type Assignments For​

 

 

 

Multi-energy CT Image” in​

 

 

 

PS3.3 this corresponds to​

 

 

 

Image Type Value 4​

>Measurement Units Code Sequence​

(0040,08EA)​

 

 

>>Include Table 8.8-1 “Code Sequence Macro Attributes” in PS3.3​

([hnsf'U], UCUM, "Hounsfield​

 

 

 

unit")​

 

>Quantity Definition Sequence​

(0040,9220)​

 

 

>>CODE (105590001, SCT, "Substance")​

 

(11713004, SCT, "Water")​

 

>>CODE (370129005, SCT, "Measurement Method")​

(129323, DCM, "Material​

 

 

 

Specific image")​

 

This example shows how to use the Table C.7.6.16-12b “Real World Value Mapping Item Macro Attributes” in PS3.3 to describe pixel​ values of the encoding of Quantitative Image Family parameters, by adding coded concepts to the RWVM that describe the material,​ the method and the value range in case of Value-based images.​

In this example, a Value-based material map image has been created where pixel values between 0 and 20 correspond to voxels​ that are associated with Uric Acid and pixel values between 20 and 40 correspond to voxels that are associated with Calcium:​

•​In the Quantity Definition Sequence (105590001, SCT, "Substance") is used to indicate that the pixel value in the specified range​ is deemed to represent the presence of that substance, regardless of the actual pixel value within that range. It would be inappro-​ priate to use (246205007, SCT, "Quantity") since the transformed pixel values do not represent a quantitative value.​

•​Themeasurementmethodof(113250,DCM,"Value-basedmaterialimage")mightbereplacedbyamorespecificcodethatactually​ described the method of computation such as "Gaussian distribution".​

•​For the sake of illustration, in this image a pixel value of 20 maps to both "Uric Acid" and "Calcium".​

- Standard -​

Page 864​ DICOM PS3.17 2020a - Explanatory Information​

Table KKKK.1-2. Example Value Based Images for the Real World Value Mapping Macro​

Attribute​

Tag​

Value​

Comment​

Real World Value Mapping Sequence​

(0040,9096)​

 

 

ITEM 1​

 

 

 

>Real World Value First Value Mapped​

(0040,9216)​

0​

 

>Real World Value Last Value Mapped​

(0040,9211)​

20​

 

>Real World Value Intercept​

(0040,9224)​

0​

 

>Real World Value Slope​

(0040,9225)​

1​

 

>LUT Explanation​

(0028,3003)​

"Value-based substance map for​

 

 

kidney stone"​

 

>LUT Label​

(0040,9210)​

MAT_ VALUE_BASED​

 

>Measurement Units Code Sequence​

(0040,08EA)​

 

 

>>Include Table 8.8-1 “Code Sequence Macro Attributes” in PS3.3​

(1, UCUM, "no units")​

 

>Quantity Definition Sequence​

(0040,9220)​

 

 

>>CODE (105590001, SCT, "Substance")​

 

(1710001, SCT, "Uric Acid")​

 

>>CODE (370129005, SCT, "Measurement Method")​

 

(129322, DCM, "Value-based​

 

 

 

image")​

 

ITEM 2​

 

 

 

>Real World Value First Value Mapped​

(0040,9216)​

20​

 

>Real World Value Last Value Mapped​

(0040,9211)​

40​

 

>Real World Value Intercept​

(0040,9224)​

0​

 

>Real World Value Slope​

(0040,9225)​

1​

 

>LUT Explanation​

(0028,3003)​

"Value-based substance map for​

 

 

kidney stone"​

 

>LUT Label​

(0040,9210)​

MAT_ VALUE_BASED​

 

>Measurement Units Code Sequence​

(0040,08EA)​

(1, UCUM, "no units")​

 

>>Include Table 8.8-1 “Code Sequence Macro​

 

 

 

Attributes” in PS3.3​

 

 

 

>Quantity Definition Sequence​

(0040,9220)​

 

 

>>CODE (105590001, SCT, "Substance")​

 

(5540006, SCT, "Calcium")​

 

>>CODE (370129005, SCT, "Measurement Method")​

 

(129322, DCM, "Value-based​

 

 

 

image")​

 

- Standard -​

DICOM PS3.17 2020a - Explanatory Information​

Page 865​

LLLL Imaging Agent Administration Report​

Template (Informative)​

LLLL.1 Purpose of this Annex​

This Annex describes some use cases of the contrast agent administration reporting. The contrast agent administration report object​ records the planned and performed delivery of contrast agents.​

A Planned Imaging Agent Administration SR object is intended for representing the plan or program to deliver contrast agent to the​ patient for a contrast study. It could be prepared and customized for a patient by the radiologist, prior to the study. The plan may also​ be altered by the operating technologist prior to the study. For example, the injection plan might be adjusted for patient's condition​ such as weight. The plan is then loaded into the injector system to be performed.​

A Performed Imaging Agent Administration SR object is for reporting the actual program that was used to deliver the contrast agent​ during the study. During the study, the contrast-delivery system may alter the original delivery plan as a result of events that occur​ during the delivery of Imaging Agent such as limiting the flow rate due to high pressure, aborting the injection due to adverse events,​ etc. The Performed Image Agent Administration SR is then saved.​

The infusion manager sends the Performed Imaging Agent Administration SR to the PACS and optionally to other destinations like​ an acquisition modality, RIS, or reporting system.​

Figure LLLL.1-1 illustrates possible consumers of the Performed Imaging Agent Administration SR object (referred as "Imaging Agent​ Administration SR" in the figure) post administration.​

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Imaging Agent

 

 

 

Modality

 

 

 

 

 

 

 

 

 

Administration SR

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

RIS

 

 

Imaging Agent

 

Contrast Infusion

 

 

 

Imaging Agent

 

 

 

PACS

 

 

Administration SR

 

Manager

 

 

Administration SR

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Imaging Agent

 

 

 

Reporting System

 

 

 

 

 

 

 

 

 

Administration SR

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Figure LLLL.1-1. Possible Consumers of the Performed Imaging Agent Administration SR Object​

LLLL.2 Use Cases​

Note​

In the following use cases, the word event means a combination of injector and adverse events.​

LLLL.2.1 Use Case 1 - Manual Bolus Injection​

The use case shown in Figure LLLL.2-1 is an example of how a performed object can capture a manual contrast infusion. The oper-​ ator performs a manual administration of contrast for a study. The operator selects the patient from the contrast infusion manager​ (available through modality worklist) and reports the minimum parameters about the injection. The contrast infusion manager then​ generates a Performed Imaging Administration SR object and sends to the Contrast Usage Consumer such as PACS.​

- Standard -​

Page 866​

DICOM PS3.17 2020a - Explanatory Information​

Operator

Contrast Infusion

Contrast Usage

RIS

Manager

Consumers

 

 

Preparation

Note

The procedure details contain information expected by the infusion informer / infusion action informer may use procedure code, procedure name or explicit contrast reference. The mechanism that steers this information into the Infusion Manager is not addressed.

Patient and Study context

Patient / Study selection

Create explict

Contrast Usage plan

Administration

Note

As many or as few details as possible - since it’s manual, only limited information is expected. (e.g., total volume, average flow rate, etc.)

Register contrast usage details

Contrast Report Use

Imaging Agent Administration SR

Figure LLLL.2-1. Use Case 1 - Manual Bolus Injection​

LLLL.2.2 Use Case 2 - Automatic Infusion Pump - Contrast Reporting​

The use case shown in Figure LLLL.2-2 is an example of how a performed object could be used for capturing an automatic infusion.​ The technologist selects a patient at the infusion manager from the work list available from the scheduling system and then performs​ anautomatedadministrationofcontrastfortheselectedpatient.Theinfusionmanagerrecordsvariouseventsduringtheadministration.​ The data from the injector events and from the adverse events that occurred during the administration are captured and obtained by​ the infusion manager.​

Upon completion of the administration procedure, the infusion manager generates a Performed Imaging Agent Administration SR​ objectusingtheinjectiondataobtainedfromtheinjectionsystemandincludingtheeventsandupdatedparametersthatwerecaptured​ during the administration. The generated report is then sent to the PACS and other contrast usage consumers.​

- Standard -​

 

DICOM PS3.17 2020a - Explanatory Information​

Page 867​

 

Operator

Contrast Infusion

Contrast Infusion

Contrast Usage

RIS

 

 

System

 

Manager

Consumers

 

 

 

 

 

Preparation

 

 

 

 

 

Patient and Study context

 

 

 

 

 

 

 

 

 

 

Patient / Study selection

 

 

 

Administration

Program infusion

 

 

 

 

 

 

Start infusion

 

 

 

 

 

 

 

 

 

 

Start infusion event

 

 

 

 

e.g., Pressure limit reached

 

Pump infusion event

 

 

 

 

 

 

 

 

 

flow rate limited

 

 

 

 

 

 

e.g., Pressure limit reached

Adjust settings

 

 

 

 

 

 

flow rate limited

 

 

 

 

 

 

 

 

 

Update parameters

 

 

 

 

 

 

 

 

 

 

 

e.g.,Extravasation

 

 

Pump infusion event

 

 

 

 

 

 

Pump infusion event

 

 

e.g., Increase volume to

Adjust settings

 

 

 

 

 

 

compensate for extravasation

 

 

 

Update parameters

 

 

 

e.g.,Validate

Modify / Correct

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Infusion finished

 

 

 

 

 

 

 

Infusion finished

 

 

 

Contrast Report Use

 

 

 

 

Imaging Agent Administration SR

 

 

 

 

 

 

Contrast Report

 

Figure LLLL.2-2. Use Case 2 - Automatic Infusion Pump - Contrast Reporting​

LLLL.2.3 Use Case 3 - Protocoling​

The use case shown in Figure LLLL.2-3 is an example of how a planned object could be used. The radiologist uses the protocoling​ application in order to plan the contrast administration protocol for a patient. The protocoling application outputs the planned object​ into the infusion manager for immediate use or to the RIS or PACS. The planned object is used by the technologist during the study.​

Protocoling

 

RIS

 

PACS

 

Contrast Infusion

Application

 

 

 

Manager

 

 

 

 

 

 

 

 

 

 

 

 

Worklist Query

Procedure Steps

Radiologist starts new case

Requests prior performed SR

Return prior performed SR

Radiologist reviews orders

Radiologist customizes injection protocol for patient

Alternative 1

Register contrast usage details

Query contrast usage details

Provide contrast usage details

Alternative 2

Register contrast usage details

Figure LLLL.2-3. Use Case 3 - Protocoling​

- Standard -​

Page 868​

DICOM PS3.17 2020a - Explanatory Information​

LLLL.2.4 Use Case 4 - Consumption of the Contrast Information by Reporting Systems for​ Automated Documentation​

This use case gives an example of how a Performed Imaging Agent Administration SR object could be used for capturing summary​ valuesofcontrastintoaradiologyreportingsystem.Inthiscase,theradiologyreportingsystemwouldbeaContrastUsageConsumer​ (Figure LLLL.2-2).​

The most straightforward and ubiquitous need for the contrast administration record is in the radiologist reporting workflow. Inclusion​ of delivered contrast data into templates or sections of the report is mandated in some regions of the world as evidence for billing​ reconciliation. More generally, the radiologist can include this data for completeness of study documentation. Ostensibly, contrast​ data included in reports may be used to construct a longitudinal record of contrast exposure for a patient undergoing multiple imaging​ studies.​

Data of primary importance in this workflow are the summary values of contrast administered to the patient (total volume of contrast,​ saline, flow rate and concentration/type of contrast used). Often, information describing the vascular access device used (e.g., cath-​ eter gauge) is clinically relevant and/or mandated.​

The guidance from ACR [ACR Communication] about the procedures and materials description in the report body states, “The report​ shouldincludeadescriptionofthestudiesand/orproceduresperformedandanycontrastmediaand/orradiopharmaceuticals(including​ specificadministeredactivities,concentration,volume,androuteofadministrationwhenapplicable),medications,catheters,ordevices​ used, if not recorded elsewhere”.​

LLLL.3 Informative References​

[ACR Communication] American College of Radiology. 2014. Resolution 11. ACR Practice Parameters and Technical Standards -​ Practice Guideline for Communication of Diagnostic Imaging Findings. http://www.acr.org/-/media/ACR/Files/​ Practice-Parameters/CommunicationDiag.pdf .​

- Standard -​

DICOM PS3.17 2020a - Explanatory Information​

Page 869​

MMMM Performed Imaging Agent​ Administration Structured Report​ (Informative)​

This Annex describes the use of Imaging Agent Administration Structured Report objects.​

MMMM.1 Performed Imaging Agent Administration Structured Report​

This Section contains examples for use cases involving contrast imaging of a single patient in CT system.​

In the basic use case:​

•​Patient was scheduled by RIS system with a study UID and accession number.​

•​An Injection procedure for the study was described by an IAASR plan object.​

•​Patient suffers from insufficient renal function, so intravenous (i.v.) contrast agents were dissolved to achieve necessary volumes.​

•​Before i.v. contrast was administered a 10 mg Prednisone injection was given to the patient.​

•​Afterconnectingthepatienttotheinjectionsystem,apatencytestinjectionwasdone.(Theinjectionsystemdoesnotrecorddetailed​ graph information of this.)​

•​"Keep vein open" was activated at a rate of 1 ml per minute.​

•​The Requested Procedure was a CT abdominal study with both i.v. and oral contrast administration.​

•​Oral contrast media OralContrastofin was diluted to 25:1000 as given in the drug usage description. 1000 ml of oral contrast​ mediawasgiven2hoursinadvanceoftheprocedure.(Preparationof1000mlsolutionuses24.4mlcontrastand975.6mlwater)​

•​Test bolus and Imaging injection phase was done at 3 ml/s and were followed by a 30 ml flush at the same flow rate.​

•​Before the diagnostic injection, a test bolus of 10 ml undiluted ContrastStuff 370 contrast was given, in order to determine scan​ delay time for the diagnostic injection.​

•​Finally 88 ml i.v. contrast media ContrastStuff 370 (corresponding to 0.5 g iodine / kg body weight for a 65 kg person) was given​ during imaging. Due to the high viscosity of the contrast and renal insufficiency of the patient, ContrastStuff 370 was diluted 1:1​ with 88 ml flush on the fly during injection.​

The content tree structure would resemble:​

Node​

Code Meaning of Concept​ Code Meaning or Example Value​

Reference to TID/ CID/ Comments​

 

Name​

 

 

1​

Performed Imaging Agent​

 

TID 11020​

 

Administration​

 

 

1.1​

Language of Content Item​

English​

TID 11020​

 

and Descendants​

 

TID 1204​

 

 

 

1.1.1​

Country of Language​

United States​

TID 1204​

1.2​

Observer Type​

Person​

TID 1002​

 

 

 

CID 270​

1.3​

Person Observer Name​

Doe^Jane​

TID 1003​

- Standard -​

Page 870​

DICOM PS3.17 2020a - Explanatory Information​

 

Node​

Code Meaning of Concept​ Code Meaning or Example Value​

Reference to TID/ CID/ Comments​

 

Name​

 

 

1.4​

Observer Type​

Device​

TID 1002​

 

 

 

Since Observer Type is Device​

1.5​

Device Observer UID​

1.2.3.4.47110815.1​

TID 1004​

1.6​

Device Observer​

Injector Corporation​

TID 1004​

 

Manufacturer​

 

 

1.7​

Device Observer Model​

XYZ INJECTOR​

TID 1004​

 

Name​

 

 

1.8​

Device Observer Serial​

1234567890​

TID 1004​

 

Number​

 

 

1.9​

Station AE Title​

XYZINJAET​

TID 1004​

1.10​

Procedure Study Instance​

1.2.3.4.47110815.2​

TID 1005​

 

UID​

 

Defaults to Study Instance UID​

 

 

 

 

 

 

(0020,000D) of General Study Module​

1.11​

Accession Number​

123456789​

TID 1005​

 

 

 

Defaults to (0008,0050)​

1.12​

Medication given​

 

TID 8131​

1.12.1​

Route of administration​

(47625008, SCT, "Intravenous route")​

TID 8131​

 

 

 

CID 11​

1.12.2​

Mixture​

 

TID 8131​

1.12.2.1​

Drug administered​

Prednisone​

TID 8131 row 7​

1.12.2..2​

Medication Type​

(130259, DCM, "Contrast Reaction​

TID 8131​

 

 

Prophylactic Agent")​

CID 76​

 

 

 

1.12.2.3​

Dosage​

2 ml​

TID 8131​

 

 

 

CID 82 (Units)​

1.12.2.4​

Concentration​

5 mg/ml​

TID 8131​

 

 

 

CID 82 (Units)​

1.13​

Patient Characteristics​

 

TID 10024​

1.13.1​

Patient State​

(414417004, SCT, "History of renal failure")​TID 10024​

 

 

 

CID 64​

1.13.2​

Subject Age​

25​

TID 10024​

 

 

 

CID 7456​

 

 

 

UNITS=EV (a, UCUM, "year")​

1.13.3​

Subject Sex​

(M, DCM, "Male")​

TID 10024​

 

 

 

CID 7455​

1.13.4​

Patient Height​

175​

TID 10024​

 

 

 

UNITS=EV (cm, UCUM, "cm")​

1.13.5​

Patient Weight​

65​

TID 10024​

 

 

 

UNITS=EV (kg, UCUM, "kg")​

- Standard -​

Соседние файлы в папке PS-2020a